Balanced news tone
News Sentiment
STE sentiment intelligence
STERIS plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-1.0% over one week, +4.1% over four weeks, trend inactive, and near fair-value range.
Steris stock reflects steady growth as infection prevention demand supports long-term outlook
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Steris stock reflects steady growth as infection prevention demand supports long-term outlook
Steris plc, a global leader in infection prevention and sterile services, is positioned for long-term growth due to steady demand from healthcare systems and life sciences industries. The company's business model, which includes equipment, consumables, and outsourced services, pr
- Tone
- Positive 73/100
- Event
- Guidance
- Published
- 16 Jul 2026 00:52
- Source
- Ad-hoc-news.de
Steris PLC stock outperforms competitors on strong trading day
Steris PLC's stock advanced by 1.31% to $211.46 on Wednesday, outperforming the broader market. This occurred on a strong trading day where the S&P 500 rose 0.38% and the Dow Jones Industrial Average increased by 0.29%. Despite the daily gain, the company's stock closed 21.52% be
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 15 Jul 2026 20:05
- Source
- MarketWatch
Principal Financial Group Inc. Grows Stock Holdings in STERIS plc $STE
Principal Financial Group Inc. increased its stake in STERIS plc ($STE) by 1.0% in Q1, ending with 890,562 shares valued at approximately $196.9 million. STERIS reported Q4 earnings of $2.83 EPS, slightly below estimates, with revenue of $1.59 billion, up 6.7% year over year. The
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 15 Jul 2026 10:08
- Source
- MarketBeat
Steris stock reflects steady healthcare demand as investors eye infection-prevention growth
Steris plc (IE00BFY8C754) is a global provider of infection-prevention, sterilization, and surgical products and services, primarily in healthcare and life sciences. The company's stock is considered defensive due to steady demand for sterile processing, recurring service revenue
- Tone
- Positive 76/100
- Event
- Earnings
- Published
- 15 Jul 2026 07:03
- Source
- Ad-hoc-news.de
Steris PLC (STE) Stock Down 3.8% -- Now Undervalued? GF Score: 8
Steris PLC (STE) stock recently dropped 3.8% to $208.73, positioning it as undervalued according to GuruFocus's metrics, trading 22.6% below its GF Value™ of $269.75. Despite a strong GF Score™ of 86/100, indicating robust financial health, profitability, and growth, investor cau
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 14 Jul 2026 22:22
- Source
- GuruFocus
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Steris PLC stock underperforms Tuesday when compared to competitors
Steris PLC's stock (STE) fell by 3.83% to $208.73 on Tuesday, underperforming the broader market despite gains in the S&P 500 and Dow Jones Industrial Average. The company's shares closed 22.53% below its 52-week high of $269.44, achieved on January 16th.
- Tone
- Negative 20/100
- Event
- Market update
- Published
- 14 Jul 2026 17:05
- Source
- MarketWatch
Enterprise value to revenue forward of STERIS plc – LSE:0XI8
This article provides a financial overview of STERIS plc (LSE:0XI8), focusing on its enterprise value to revenue forward metric. It lists various financial data sources and sections available on the TradingView platform for the company, such as financials, news, community insight
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 15:39
- Source
- TradingView
Enterprise value to EBIT forward of STERIS plc – LSE:0XI8
This article provides financial information for STERIS plc (LSE:0XI8), specifically focusing on its enterprise value to EBIT forward. It includes links to various financial data, news, and community discussions about the company, as well as general TradingView platform resources.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 11:39
- Source
- TradingView
STERIS Plc (STE) Stock Analysis: Unveiling A Promising 18.92% Potential Upside
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 09:17
- Source
- DirectorsTalk Interviews
Steris stock reflects steady demand as infection prevention business supports long-term growth
Steris plc offers investors exposure to a global leader in infection prevention and sterilization solutions for healthcare and life science sectors, characterized by a resilient business model supported by recurring revenue. The company's focus on essential healthcare infrastruct
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:37
- Source
- Ad Hoc News
Sumitomo Mitsui Trust Group Inc. Sells 10,552 Shares of STERIS plc $STE
Sumitomo Mitsui Trust Group Inc. reduced its stake in STERIS plc by 4.8% in the first quarter, selling 10,552 shares and now owning 208,697 shares valued at $46.15 million. Despite this, other institutional investors like Vanguard Group, State Street Corp, and AQR Capital Managem
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:03
- Source
- MarketBeat
Enterprise value to EBITDA forward of STERIS plc – LSE:0XI8
This article provides financial information for STERIS plc (LSE:0XI8) on TradingView, specifically focusing on its Enterprise Value to EBITDA forward metric. It outlines that the market was closed with no trades at the time of publication and directs users to various financial da
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 02:38
- Source
- TradingView
Price to sales forward of STERIS plc – LSE:0XI8
This article provides the "Price to sales forward" metric for STERIS plc (LSE:0XI8). It indicates that the market is currently closed with no trades recorded for this particular metric. The content was retrieved from TradingView, which aggregates financial data from various sourc
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 22:08
- Source
- TradingView
Price to book forward of STERIS plc – LSE:0XI8
This article provides access to the "Price to book forward" financial metric for STERIS plc (LSE:0XI8) on the TradingView platform. It lists the period, value, change, and change percentage for this specific financial ratio. The content is primarily a data point intended for fina
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 21:08
- Source
- TradingView
Kornitzer Capital Management Inc. KS Takes Position in STERIS plc $STE
Kornitzer Capital Management Inc. KS has initiated a new position in STERIS plc (NYSE:STE) during the first quarter, acquiring 24,900 shares valued at approximately $5.5 million. STERIS reported quarterly earnings of $2.83 per share, slightly missing analyst expectations, while r
- Tone
- Positive 61/100
- Event
- Earnings
- Published
- 12 Jul 2026 17:15
- Source
- MarketBeat
Steris plc stock holds steady as infection prevention demand supports long-term growth
Steris plc stock reflects a stable business focused on infection prevention, sterilization, and procedural support for healthcare and life sciences. The company benefits from recurring demand driven by rising healthcare spending, aging populations, and increased attention to infe
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 11 Jul 2026 23:14
- Source
- ad-hoc-news.de
STERIS plc $STE Shares Acquired by Villere ST Denis J & Co. LLC
Villere ST Denis J & Co. LLC increased its stake in STERIS plc (NYSE:STE) by 8.1% in the first quarter, now holding 108,763 shares valued at approximately $24.1 million. This makes STERIS about 2.7% of the firm’s investment portfolio. The medical equipment provider recently repor
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 11 Jul 2026 15:58
- Source
- MarketBeat
Steris stock holds steady as medical sterilization demand underpins long term growth
Steris plc, trading on the NYSE under STE, focuses on infection prevention and sterile processing solutions for healthcare and life sciences. The company's business model relies on a mix of capital equipment, consumables, and recurring services, supporting long-term growth driven
- Tone
- Positive 92/100
- Event
- Macro sensitivity
- Published
- 10 Jul 2026 14:46
- Source
- Ad Hoc News
STERIS plc $STE Shares Acquired by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd significantly increased its holdings in STERIS plc (NYSE:STE) by 652.7% in the first quarter, now owning 7,286 shares valued at $1.61 million. Analysts maintain a "Moderate Buy" consensus rating with a target price of $278, despite the company missing EP
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jul 2026 10:09
- Source
- MarketBeat
Steris stock holds steady as the medical device model stays intact
Steris plc, an Ireland-domiciled company, maintains a stable medical technology profile through its specialization in sterilization, surgical, and infection prevention products for healthcare and life sciences customers. Its business model relies on recurring consumables, equipme
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 10 Jul 2026 09:48
- Source
- Ad Hoc News
Steris PLC stock underperforms Wednesday when compared to competitors
Steris PLC (STE) stock fell 2.74% on Wednesday, closing at $209.49. This underperformance occurred during a generally negative trading session, with the S&P 500 Index and Dow Jones Industrial Average also declining. The stock is currently 22.25% below its 52-week high reached in
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 21:03
- Source
- MarketWatch
Swedbank AB Reduces Stock Position in STERIS plc $STE
Swedbank AB reduced its stake in STERIS plc by 15.9% in the first quarter, selling 43,050 shares and retaining 228,028 shares valued at approximately $50.4 million. Despite insider selling and mixed quarterly results, analysts generally maintain a "Moderate Buy" rating for STERIS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 10:09
- Source
- MarketBeat
Steris plc focuses on infection prevention. Healthcare demand supports the business
Steris plc is a global provider of infection prevention and procedural solutions for healthcare and life science customers. The company benefits from constant demand for sterilization and hygiene solutions due to the global healthcare spending and regulatory needs. Steris offers
- Tone
- Positive 71/100
- Event
- Regulatory and legal
- Published
- 08 Jul 2026 09:24
- Source
- AD HOC NEWS
STERIS stock holds steady as investors await fresh catalysts.
STERIS plc (STE) stock is trading against a quiet backdrop as the Nasdaq-listed medical technology company awaits new catalysts. The company's business model combines equipment, consumables, and service work, providing recurring revenue from its sterilization and infection-preven
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 15:22
- Source
- AD HOC NEWS
Steris stock holds steady. Business context remains the focus.
Steris plc, a healthcare infrastructure company, maintains a steady stock performance, with investors focusing on its strong presence in healthcare and life sciences. The company's business model relies on selling equipment, consumables, and service contracts for infection preven
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 12:42
- Source
- AD HOC NEWS
STERIS (STE) Faces Renewed Valuation Debate, Is Its Quality Enough To Justify The Price?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 21:37
- Source
- simplywall.st
Steris PLC stock underperforms Monday when compared to competitors
Steris PLC (STE) shares dropped 2.25% to $213.28 on Monday, underperforming the broader market. This decline occurred despite a positive trading session for the S&P 500 Index and the Dow Jones Industrial Average, both of which saw gains. The stock's fall ended a two-day winning s
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 06 Jul 2026 21:06
- Source
- MarketWatch
Steris stock and long-term growth. Investors focus on healthcare technology and sterilization demand
Steris plc is a global provider of infection prevention and procedural solutions, offering investors exposure to the growing demand for sterilization, surgical equipment, and hospital productivity. The company's business model combines manufacturing of specialized equipment with
- Tone
- Positive 76/100
- Event
- Macro sensitivity
- Published
- 06 Jul 2026 11:00
- Source
- AD HOC NEWS
STERIS Plc (STE) Stock Analysis: Strong Buy Ratings And 17.72% Upside Potential
- Tone
- Positive 95/100
- Event
- Market update
- Published
- 06 Jul 2026 09:18
- Source
- DirectorsTalk Interviews